论文信息 - A phase I study with the agonistic TRAIL-R1 antibody, mapatumumab, in combination with gemcitabine and cisplatin - 字舞流文

A phase I study with the agonistic TRAIL-R1 antibody, mapatumumab, in combination with gemcitabine and cisplatin

S. Sleijfer | J. Verweij | J. Gietema | W. Loos | N. Fox | F. Eskens | C. Mom | E. D. Vries | A. Corey | Walter J. Loos | Corina N. Oldenhuis